P2‐509: Population pharmacokinetic analysis of plasma, cerebrospinal fluid and brain ELND005 in patients with mild to moderate Alzheimer's disease
Wagg J, Green M, Yan L, Liang E, Cedarbaum J, Abushakra S. P2‐509: Population pharmacokinetic analysis of plasma, cerebrospinal fluid and brain ELND005 in patients with mild to moderate Alzheimer's disease. Alzheimer's & Dementia 2011, 7: s475-s475. DOI: 10.1016/j.jalz.2011.05.1380.Peer-Reviewed Original ResearchPopulation pharmacokinetic analysisPharmacokinetic analysisCerebrospinal fluidAlzheimer's diseaseDiseasePatients